Literature DB >> 18710384

Rituximab as treatment for minimal residual disease in hairy cell leukaemia: extended follow-up.

Giulia Cervetti, Sara Galimberti, Francesca Andreazzoli, Rita Fazzi, Nadia Cecconi, Francesco Caracciolo, Mario Petrini.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18710384     DOI： 10.1111/j.1365-2141.2008.07333.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  9 in total

1.  My treatment approach to hairy cell leukemia.

Authors:  Rahul R Naik; Alan Saven
Journal:  Mayo Clin Proc       Date:  2012-01       Impact factor: 7.616

2.  Long-term durable remission by cladribine followed by rituximab in patients with hairy cell leukaemia: update of a phase II trial.

Authors:  Dai Chihara; Hagop Kantarjian; Susan O'Brien; Jeffrey Jorgensen; Sherry Pierce; Stefan Faderl; Alessandra Ferrajoli; Rebecca Poku; Preetesh Jain; Phillip Thompson; Mark Brandt; Rajyalakshmi Luthra; Jan Burger; Michael Keating; Farhad Ravandi
Journal:  Br J Haematol       Date:  2016-06-15       Impact factor: 6.998

3.  Treatment of hairy cell leukemia during pregnancy: are purine analogues and rituximab viable therapeutic options.

Authors:  Naval Daver; Aziz Nazha; Hagop M Kantarjian; Rodney Haltom; Farhad Ravandi
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2012-09-14

Review 4.  Importance of minimal residual disease in hairy cell leukemia: monoclonal antibodies as a therapeutic strategy.

Authors:  Deborah A Thomas; Farhad Ravandi; Michael Keating; Hagop M Kantarjian
Journal:  Leuk Lymphoma       Date:  2009-10

Review 5.  Approach to the patient after relapse of hairy cell leukemia.

Authors:  Robert J Kreitman; David J P Fitzgerald; Ira Pastan
Journal:  Leuk Lymphoma       Date:  2009-10

Review 6.  Current and emerging treatment options for hairy cell leukemia.

Authors:  Montserrat López-Rubio; Jose Antonio Garcia-Marco
Journal:  Onco Targets Ther       Date:  2015-08-19       Impact factor: 4.147

7.  The Droplet Digital PCR: A New Valid Molecular Approach for the Assessment of B-RAF V600E Mutation in Hairy Cell Leukemia.

Authors:  Francesca Guerrini; Matteo Paolicchi; Francesco Ghio; Elena Ciabatti; Susanna Grassi; Serena Salehzadeh; Giacomo Ercolano; Maria R Metelli; Marzia Del Re; Lorenzo Iovino; Iacopo Petrini; Giovanni Carulli; Nadia Cecconi; Martina Rousseau; Giulia Cervetti; Sara Galimberti
Journal:  Front Pharmacol       Date:  2016-10-13       Impact factor: 5.810

8.  Hairy cell leukemia: short review, today's recommendations and outlook.

Authors:  V Maevis; U Mey; G Schmidt-Wolf; I G H Schmidt-Wolf
Journal:  Blood Cancer J       Date:  2014-02-14       Impact factor: 11.037

9.  Recommendations of the SFH (French Society of Haematology) for the diagnosis, treatment and follow-up of hairy cell leukaemia.

Authors:  Edouard Cornet; Alain Delmer; Pierre Feugier; Francine Garnache-Ottou; David Ghez; Véronique Leblond; Vincent Levy; Frédéric Maloisel; Daniel Re; Jean-Marc Zini; Xavier Troussard
Journal:  Ann Hematol       Date:  2014-07-05       Impact factor: 3.673
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.